Gene therapy for treating neurological pathologies
Investment: €626k
Scope: Healthcare
Scientific field(s): Biology and medicinal chemistry
Institution(s): Université de Versailles Saint-Quentin-en-Yvelines - AP-HP
Development: Spin-off in progress / completed
Institution(s): Université de Versailles Saint-Quentin-en-Yvelines - AP-HP
Development: Spin-off in progress / completed
